
2.24 Delayed Data As of May 25 | ![]() Today’s Change | 1.93 Today|||52-Week Range 6.50 | -42.42% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $361.4M |
Arbutus Biopharma Corp. 701 Veterans Circle Warminster Pennsylvania 18974 |
William H. Collier | President, Chief Executive Officer & Director |
David C. Hastings | Chief Financial & Accounting Officer |
Michael J. Sofia | Chief Scientific Officer |
Elizabeth Howard | Secretary, Chief Compliance Officer & EVP |
Michael J. McElhaugh | Chief Business Officer |